First Dallas Securities’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-5,879
Closed -$463K 128
2024
Q2
$463K Sell
5,879
-7,219
-55% -$592K 0.2% 85
2024
Q1
$1.14M Buy
13,098
+1,450
+12% +$124K 0.53% 46
2023
Q4
$960K Buy
11,648
+8,054
+224% +$614K 0.49% 51
2023
Q3
$282K Sell
3,594
-6,317
-64% -$529K 0.06% 129
2023
Q2
$873K Buy
9,911
+2,276
+30% +$196K 0.49% 55
2023
Q1
$616K Buy
+7,635
New +$622K 0.36% 65
2022
Q4
Sell
-2,677
Closed -$216K 119
2022
Q3
$216K Sell
2,677
-5,244
-66% -$471K 0.15% 106
2022
Q2
$711K Sell
7,921
-2,949
-27% -$299K 0.48% 55
2022
Q1
$1.21M Buy
10,870
+6,570
+153% +$694K 0.68% 43
2021
Q4
$445K Buy
4,300
+1,175
+38% +$136K 0.29% 77
2021
Q3
$392K Sell
3,125
-200
-6% -$25.9K 0.27% 83
2021
Q2
$413K Hold
3,325
0.27% 79
2021
Q1
$393K Hold
3,325
0.33% 75
2020
Q4
$389K Buy
+3,325
New +$366K 0.35% 70

Other funds holding MDT

First Dallas Securities's MDT Position: Q3 2024 in Review

First Dallas Securities sold out of Medtronic (MDT) in Q3 2024, closing a stake of 5,879 shares — an estimated $463K sold.

First Dallas Securities first reported a position in MDT in Q4 2020 and held it in 14 quarters. The position peaked at $1.21M in Q1 2022. 2,064 funds tracked by Wall St. Rank hold MDT as of Q3 2024.

  • First Dallas Securities reported no remaining Medtronic position as of Q3 2024 after selling out during the quarter.
  • First Dallas Securities sold 5,879 Medtronic shares in Q3 2024, an estimated $463K.
  • First Dallas Securities first reported a position in Medtronic in Q4 2020 and held it in 14 quarters.
  • First Dallas Securities's Medtronic position peaked at $1.21M in Q1 2022.
  • 2,064 funds tracked by Wall St. Rank held Medtronic as of Q3 2024.

Based on First Dallas Securities's 13F filing for Q3 2024, filed 18 Nov 2024.